novidades científicas Novo

16:13 European Cardiovascular Disease Statistics 2017
10:47 CETP inhibitor meets primary endpoint in CV outcome study
9:54 Arrhythmias and devices
14:31 Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial
14:18 Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism

Reparação cirúrgica da estenose mitral. Quem mais beneficia?

12 Setembro 2016

Gonçalo F. Coutinho
Cirurgião Cardiotorácico
Hospital da Universidade de Coimbra

MOGE(S):Uma classificação holística das Cardiomiopatias

12 Setembro 2016
0

Guidelines 2016 – Ten Commandments

13 Setembro 2016
0

-->